# The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population

> **NCT02973464** · — · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 450 (estimated)

## Conditions studied

- Renal Transplant Recipients

## Interventions

- **DRUG:** Valganciclovir
- **DRUG:** Ganciclovir

## Key facts

- **NCT ID:** NCT02973464
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2019-06
- **Final completion:** 2019-12
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2016-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02973464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02973464, "The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02973464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*